Justin M. Hall
2020 - NovaBay Pharmaceuticals
In 2020, Justin M. Hall earned a total compensation of $747.2K as CEO, GC and Chief Compliance Officer at NovaBay Pharmaceuticals, a 129% increase compared to previous year.
Compensation breakdown
| Bonus | $114,000 |
|---|---|
| Option Awards | $346,500 |
| Salary | $286,000 |
| Other | $720 |
| Total | $747,220 |
Hall received $346.5K in option awards, accounting for 46% of the total pay in 2020.
Hall also received $114K in bonus, $286K in salary and $720 in other compensation.
Rankings
In 2020, Justin M. Hall's compensation ranked 9,747th out of 13,090 executives tracked by ExecPay. In other words, Hall earned more than 25.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,747 out of 13,090 | 26th |
Division Manufacturing | 4,191 out of 5,621 | 25th |
Major group Chemicals And Allied Products | 1,718 out of 2,254 | 24th |
Industry group Drugs | 1,506 out of 1,954 | 23rd |
Industry Pharmaceutical Preparations | 1,110 out of 1,459 | 24th |
Source: SEC filing on April 7, 2021.
Hall's colleagues
We found three more compensation records of executives who worked with Justin M. Hall at NovaBay Pharmaceuticals in 2020.
News
NovaBay Pharmaceuticals CEO Justin Hall's 2021 pay rises 6% to $796K
March 30, 2022
NovaBay Pharmaceuticals CEO Justin Hall's 2020 pay jumps 129% to $747K
April 7, 2021
NovaBay Pharmaceuticals CFO Jason Raleigh receives $334K in 2019
April 15, 2020
YRC Worldwide CEO Darren Hawkins' 2018 pay jumps 439% to $4.4M
April 25, 2019
NovaBay Pharmaceuticals CEO John McGovern's 2018 pay jumps 64% to $742K
April 19, 2019